Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Bangladesh Health Times.
BioVersys Receives EMA Orphan Designation for the Combination of Alpibectir and Ethionamide for the Treatment of Tuberculosis
Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Orphan designation is granted to drug candidates addressing life-threatening or chronically debilitating diseases affecting fewer than 5 in 10’000 EU...
    
  D’Art Celebrates 9 Years of Legacy Shaping the Future of Retail
With 60,000 touchpoints and global presence, D’Art strengthens its legacy by turning bold ideas into impactful, real-world retail experiences. MUMBAI, INDIA, October 14, 2025 /EINPresswire.com/ -- D’Art Private Limited, a prominent leader in...
    
  Attorney General James Takes Action to Protect New Yorkers from Illegal Mercury in Skin Lightening Products
NEW YORK – New York Attorney General Letitia James today announced that her office has ordered three New York companies – Aleena Cosmetics, Axabee Skincare, and Singhcart, LLC – to immediately stop selling skin-lightening creams and other...
    
  New global report warns child marriage is evolving in 2025
TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- As the world marks International Day of the Girl on October 11, Plan International, the leading global expert on girls’ rights, warns of a dangerous evolution in child marriage. A new report finds that...
    
  Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv...
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
Approval is based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicity EC approval follows positive CHMP opinion, MHRA conditional marketing...
    
  The Slaight Family Foundation announces Red Cross as part of its emergency support funding
OTTAWA, Ontario, July 30, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross extends its gratitude to Gary Slaight and The Slaight Family Foundation for a $1 million contribution over two years, in support of humanitarian efforts in Cox’s Bazar,...
    
  Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq...
C4 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Cemsidomide Phase 1 Data in Multiple Myeloma Accepted as an Oral Presentation at the International Myeloma Society (IMS) Annual Meeting; As of the July 23, 2025, Data Cutoff, Phase 1 ORR Remains at 40% at the 75 µg Dose Level and at 50% at the 100...
Global Enzymes Market Set to Reach $20.4 Billion by 2029 | Asia-Pacific Emerges as a Hotspot
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets, the global enzymes market is experiencing robust growth, driven by innovations in biotechnology, increasing demand in biopharmaceutical production, and rising...
    
  UN refugee chief urges intensifying support for minorities in Myanmar
(MENAFN) The UN High Commissioner for Refugees, Filippo Grandi, called on the international community on Tuesday to increase assistance for Rohingya Muslims and other minority groups from Myanmar, warning that gaps in funding are placing lives at...
    
  Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
REYKJAVIK, Iceland, July 10, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda...
    
  UN Refugee Chief Urges Increased Aid to Myanmar Minorities
(MENAFN) The United Nations High Commissioner for Refugees, Filippo Grandi, on Tuesday appealed to the global community to intensify its assistance for the Rohingya Muslim population and other minority groups originating from Myanmar. He cautioned...
    
  Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland
REYKJAVIK, Iceland and BURGDORF, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...
NY's Galleria on Third Launches New Artwork Collection and Benefit Art Show
Galleria on Third Launches New Artwork Collection and Benefit Art Show Celebrating NYC, Soccer, and Creativity While Supporting Children in Need NEW YORK, NY, UNITED STATES, September 26, 2025 /EINPresswire.com/ -- One of New York City’s most...
    
  Asia Pacific Fertilizers Market Size to Worth USD 313.44 Billion by 2034
Ottawa, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The Asia Pacific fertilizers market size was valued at USD 168.71 billion in 2024 and is expected to hit around USD 313.44 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.39% over...
Introducing Amaira Mart: Redefining Retail with Quality, Value, and Convenience
Amaira Mart redefines modern shopping with handpicked products, unbeatable prices, and seamless customer experience. DHAKA, DHAKA, BANGLADESH, July 2, 2025 /EINPresswire.com/ -- Amaira Mart Launches: Your New Destination for Affordable, Stylish,...
    
  Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
REYKJAVIK, Iceland, June 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders...
    
  WHO Says Rubella Eliminated in Nepal
(MENAFN) The World Health Organization (WHO) announced on Monday that Nepal has successfully eliminated rubella as a public health concern. “Nepal’s success reflects the unwavering commitment of its leadership, persistent efforts of the healthcare...
    
  Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT
REYKJAVIK, Iceland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial...